Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This chart represents the research and development (R&D) expenses of the French pharmaceutical group Guerbet from 2012 to 2018, as a share of revenue. In 2018, R&D expenses accounted for approximately nine percent of Guerbet's turnover.
Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Breakdown of Guerbet's share capital 2018, by shareholder
- Premium Statistic France: breakdown of Guerbet turnover in 2018, by product type
- Basic Statistic Breakdown of employees of Guerbet 2018, by continent
- Basic Statistic Guerbet employees by continent 2017
- Premium Statistic France: breakdown of Guerbet's turnover from 2013 to 2018, by geographical area
- Premium Statistic Global diagnostic imaging market shares of top medtech companies 2017 and 2024
- Basic Statistic Employment in California's life science industry in 2022, by sector
- Premium Statistic General Electric revenue in the Healthcare segment 2008-2022
- Basic Statistic Top health care services companies in R&D spending growth 2021/22
- Premium Statistic Top health care services companies by capex growth in 2021/22
About the region
10
- Basic Statistic France: research and development expenditure of Guerbet 2012-2018
- Basic Statistic France: volume of equity of Guerbet 2012-2018
- Basic Statistic Net financial debts of Guerbet 2012-2018
- Basic Statistic Guerbet's investments 2012-2018
- Premium Statistic France: annual turnover of Guerbet 2012-2018
- Premium Statistic France: Current operating income of Guerbet 2012-2018
- Premium Statistic France: net result of Guerbet 2012-2018
- Premium Statistic France: net earnings per share of Guerbet 2012-2018
- Basic Statistic France: dividend per share of Guerbet 2012-2018
- Basic Statistic Abbott's total operating expenses 2014-2023
Selected statistics
1
Other regions
9
- Premium Statistic MRI exams number per 1,000 people in Canada 2019/2020, by province
- Premium Statistic MRI scans number change 2016 vs. 2017 U.S., by facility type
- Basic Statistic MRI units per million: by country 2021
- Premium Statistic LabCorp number of employees 2014-2023
- Basic Statistic Life sciences wages in California in 2019, by industry sector
- Premium Statistic Value of diagnostic imaging in MedTech market in India 2008-2020
- Premium Statistic CAGR of the medical imaging information systems market in the EU5 countries 2008-2022
- Premium Statistic R&D spending in the pharmaceutical industry in Argentina 2016-2020
- Premium Statistic Mexico medical device industry production 2016-2020
Related statistics
10
- Premium Statistic Number of ultrasound procedures in France 2015, by nature
- Premium Statistic Number of CT scans in France 2015, by nature
- Premium Statistic Number of radiographic documents in France 2015, by nature
- Premium Statistic Number of medical imaging acts in France 2015, by type
- Premium Statistic Ionizing radiation exposure related to medical diagnosis in France 2012, by type
- Premium Statistic Producers of medical devices in France 2011, by company size
- Premium Statistic Time to obtain appointments for an MRI exam in France 2004-2018
- Premium Statistic Annual evolution of the number of MRIs in France 2005-2018
- Premium Statistic Number of medical imaging equipment in France 2010-2015, by type
- Premium Statistic Average cost of medical imaging for health insurance in France 2014
Further related statistics
10
- Structure of investment portfolio of Allianz Group 2014-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Number of mutual funds worldwide 2011-2014, by country
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Skincare market value in Great Britain 2009-2022
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
Further Content: You might find this interesting as well
Statistics
- Structure of investment portfolio of Allianz Group 2014-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Number of mutual funds worldwide 2011-2014, by country
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Skincare market value in Great Britain 2009-2022
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
Guerbet. (March 27, 2019). Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue [Graph]. In Statista. Retrieved May 15, 2024, from https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/
Guerbet. "Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue." Chart. March 27, 2019. Statista. Accessed May 15, 2024. https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/
Guerbet. (2019). Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue. Statista. Statista Inc.. Accessed: May 15, 2024. https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/
Guerbet. "Guerbet's Amount Spent on Research and Development from 2012 to 2018, as a Share of Revenue." Statista, Statista Inc., 27 Mar 2019, https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/
Guerbet, Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue Statista, https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/ (last visited May 15, 2024)
Guerbet's amount spent on research and development from 2012 to 2018, as a share of revenue [Graph], Guerbet, March 27, 2019. [Online]. Available: https://www.statista.com/statistics/1072658/expenses-research-development-french-group-guerbet-percentage-figure-business/